Phase II Trial of Neoadjuvant Thymalfasin, PD-1 Inhibitor, and Chemoradiotherapy for cStage III GEJ Adenocarcinoma

NCT07277439 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer

Interventions

OTHER: Radiochemoimmunotherapy
OTHER: Immunomodulation

Sponsor

The First Affiliated Hospital with Nanjing Medical University